Press Releases

Date Title and Summary Additional Formats
Toggle Summary Streamline Health® Reports Fourth Quarter And Fiscal Year 2016 Financial Performance
Fourth Quarter Revenues $6.4 Million; $5.7 Million Cash on Hand; FY 2016 Revenues $27.1 Million; $1.0 Million in Cash from Operations; $5.2 Million 2016 Net Loss; 2016 Adjusted EBITDA $2.9 Million
View HTML
Toggle Summary Streamline Health® Reports Fourth Quarter And Fiscal Year 2017 Financial Performance
Fourth Quarter Revenues $6.1 Million; $4.6 Million Cash on Hand; FY 2017 Revenues $24.3 Million; $2.0 Million in Cash from Operations; $3.1 Million Net Loss; 2017 Adjusted EBITDA $2.8 Million ATLANTA , April 25, 2018 /PRNewswire/ --  Streamline Health Solutions, Inc.
View HTML
Toggle Summary Streamline Health® Reports Fourth Quarter And Fiscal Year 2018 Financial Performance
Atlanta, GA – April 22, 2019 – Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises, today announced financial results for the fourth quarter and fiscal year 2018, which ended January 31, 2019.
View HTML
Toggle Summary Streamline Health® Reports Fourth Quarter and Fiscal Year 2019 Financial Results
Fourth Quarter 2019 revenue $4.8 million ; Net Loss ( $2.4 million ); Adjusted EBITDA $479,000 Fiscal Year 2019 revenue $20.7 million ; Net Loss ( $2.9 million ); Adjusted EBITDA $3.1 million Atlanta, GA , April 22, 2020 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc.
View HTML
Toggle Summary Streamline Health® Reports Fourth Quarter and Fiscal Year 2020 Financial Results
Fiscal 2020 Revenues of $11.3 million ; $0.3 million Net Income; Adjusted EBITDA ( $1.9 million ) Atlanta, GA , April 21, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator ™ Revenue Integrity Program to help healthcare providers proactively address
View HTML
Toggle Summary Streamline Health® Reports Fourth Quarter Fiscal Year 2012 Financial Results; 49% Increase In Revenue; 11% Increase In Adjusted EBITDA*
Total FY 2012 Revenue and Adjusted EBITDA* Increased 39% and 52% RespectivelyBacklog Increased 86% to $51.0 Million
View HTML
Toggle Summary Streamline Health® Reports Fourth Quarter Fiscal Year 2013 Revenues Of $6.5 Million
Total FY 2013 Revenues Were $28.5 Million; Sales Backlog $56.6 Million
View HTML
Toggle Summary Streamline Health® Reports Improved Income and EPS For Third Quarter 2012
Adjustment in Tax Valuation Allowance Improves Quarterly Net Income to $2.3 Million and EPS to $.18
View HTML
Toggle Summary Streamline Health® Reports Q2 Results
22% INCREASE IN REVENUE; 61% INCREASE IN ADJUSTED EBITDA*
View HTML
Toggle Summary Streamline Health® Reports Second Quarter 2014 Revenues of $7.2 Million; Adjusted EBITDA $0.5 Million
Second Quarter Recurring Revenue Up 12% Over Q2 2013
View HTML